Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
Hong Kong Med J ; 23(2): 191-201, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28387202

RESUMEN

INTRODUCTION: In Hong Kong, the prevalence of atherosclerotic cardiovascular disease has increased markedly over the past few decades, and further increases are expected. In 2008, the Hong Kong Cardiovascular Task Force released a consensus statement on preventing cardiovascular disease in the Hong Kong population. The present article provides an update on these recommendations. PARTICIPANTS: A multidisciplinary group of clinicians comprising the Hong Kong Cardiovascular Task Force-10 cardiologists, an endocrinologist, and a family physician-met in September 2014 and June 2015 in Hong Kong. EVIDENCE: Guidelines from the American College of Cardiology/American Heart Association, the European Society of Hypertension/European Society of Cardiology, and the Eighth Joint National Committee for the Management of High Blood Pressure were reviewed. CONSENSUS PROCESS: Group members reviewed the 2008 Consensus Statement and relevant international guidelines. At the meetings, each topical recommendation of the 2008 Statement was assessed against the pooled recommendations on that topic from the international guidelines. A final recommendation on each topic was generated by consensus after discussion. CONCLUSIONS: It is recommended that a formal risk scoring system should be used for risk assessment of all adults aged 40 years or older who have at least one cardiovascular risk factor. Individuals can be classified as having a low, moderate, or high risk of developing atherosclerotic cardiovascular disease, and appropriate interventions selected accordingly. Recommended lifestyle modifications include adopting a healthy eating pattern; maintaining a low body mass index; quitting smoking; and undertaking regular, moderate-intensity physical activity. Pharmacological interventions should be selected as appropriate after lifestyle modification.


Asunto(s)
Antihipertensivos/uso terapéutico , Aterosclerosis/prevención & control , Enfermedades Cardiovasculares/prevención & control , Hipolipemiantes/uso terapéutico , Estilo de Vida , Adulto , Comités Consultivos , Anciano , Anciano de 80 o más Años , Aterosclerosis/tratamiento farmacológico , Presión Sanguínea , Enfermedades Cardiovasculares/tratamiento farmacológico , Femenino , Hong Kong , Humanos , Hipertensión/tratamiento farmacológico , Hipertensión/prevención & control , Masculino , Persona de Mediana Edad , Medición de Riesgo , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda